Brokerage Reports: Jefferies on Reliance Industries: Buy, Target Rs 1700, JPMorgan on ER&D: KPIT Tech, Persistent, Tata Elxsi, Kotak on Emcure: Buy, Target Rs 1680, Citi on L&T Finance: Buy, Target Rs 221

Brokerage Reports: Jefferies on Reliance Industries: Buy, Target Rs 1700, JPMorgan on ER&D: KPIT Tech, Persistent, Tata Elxsi, Kotak on Emcure: Buy, Target Rs 1680, Citi on L&T Finance: Buy, Target Rs 221

Jefferies on Reliance

Rating: Maintain Buy with a target price of Rs 1700.

Outlook: The risk-to-reward for Reliance is compelling.

Refining: Expect a year-on-year improvement in Singapore Gross Refining Margins (SGP GRM) in CY25, as the supply-demand situation in refining becomes more favorable.

Jio: Jio’s strong growth in home broadband subscribers positions it well for 5G monetization.

Public Listing: Likely to see a public listing in CY25.

Retail: Retail performed well in October, but a sustained recovery could take up to two quarters.

Valuation: The current valuation implies a $57 billion valuation for Retail, which Jefferies considers pessimistic.

JPMorgan on ER&D Services

Overview: The growth premium for ER&D services compared to IT has decreased, but it’s expected to increase again next year.

Auto Sector: The weakness in the automotive sector is seen as temporary, and growth is expected to pick up next year.

Telecom: The ER&D sector’s premium will not return to previous highs due to ongoing challenges in the telecom sector.

Preferred Stocks:

KPIT Tech: Maintain Overweight with a target price of Rs 1900.

Persistent: Maintain Overweight with a target price of Rs 6100.

L&T Tech: Maintain Overweight with a target price of Rs 6300.

Cyient: Maintain Overweight with a target price of Rs 2250.

Tata Elxsi: Maintain Underweight with a target price of Rs 6400.

Tata Tech: Maintain Underweight with a target price of Rs 800.

Jefferies on Real Estate

Residential Markets: The real estate market had a strong start to the busy season, with sales in October reaching a 6-month high.

Sales Trends: Value sales are up more than 20% due to a better mix of products and pricing.

Future Outlook: Many large new launches are expected in the second half of the year, which will likely lead to strong sales.

Growth: Listed developers are expected to see pre-sales growth of around 25% for FY25, even though Q2 was weak.

Stock Picks: Prefer stocks such as Godrej Properties, Lodha, and DLF.

JPMorgan on Defence

BEL: Initiate Overweight with a target price of Rs 340.

Hindustan Aeronautics: Initiate Overweight with a target price of Rs 5135.

Mazagon Dock: Initiate Neutral with a target price of Rs 4248.

Growth Prospects: The defence sector has strong growth potential, and recent stock price corrections are seen as a buying opportunity.

Key Pick: BEL is seen as the best option for exposure to long-term growth in defence production and exports.

Kotak Securities on Emcure

Rating: Upgrade to Buy from Add, with a target price of Rs 1680.

Growth Outlook: Emcure’s organic growth is expected to improve in the second half of the year, especially due to new licensing deals with Sanofi and the consolidation of Mantra.

EPS Growth: The company is expected to see a 29% compound annual growth rate (CAGR) in EPS, driven by higher utilization, lower interest costs, and more positive outcomes.

JPMorgan on Bharti Hexacom

Rating: Maintain Overweight with a target price of Rs 1630.

Business Model: The ‘social’ impact of the business model is often overlooked.

Financial Performance: The company continues to have top operational and financial metrics.

Network Expansion: Bharti’s network expansion is not only growing its social reach but also boosting market share.

ESG: Bharti’s environmental, social, and governance (ESG) efforts are potentially underappreciated in the market.

UBS on Swiggy

Rating: Initiate Buy with a target price of Rs 515.

Growth Potential: Swiggy is well-positioned for growth, currently trading at a 35% discount compared to Zomato.

Online Food Delivery: Swiggy’s margins and scale are catching up to Zomato’s, with similar GMV (Gross Merchandise Value) growth expected from FY24-27.

Goldman Sachs on Sun Pharma

Rating: Sell with a target price of Rs 1600.

R&D and Cost Outlook: Sun Pharma has reduced its R&D guidance to 7-8% of sales due to delays in the GL0034 clinical trials, which are now expected to push into FY26.

Jefferies on Real Estate

Market Update: Residential markets saw a festive boost in October, with sales reaching a 6-month high.

Sales Growth: Value sales grew by 20%+, aided by better product mix and pricing.

Outlook: Expect good sales to help listed developers post 25% pre-sales growth for FY25.

Stock Picks: Prefer Godrej Properties, Lodha, and DLF.

Citi on L&T Finance

Rating: Buy with a target price of Rs 221.

Growth Plans: L&T Finance aims to double its book size in the next 3-4 years, expecting a 20-25% CAGR in AUM (Assets Under Management).

Credit Costs: The credit cost is expected to stabilize between 2.0-2.25%, supporting a steady return on assets (ROA) of 2.8-3.0%, despite a reduction in MFI (Microfinance) exposure.

More From Author

Brokerage Reports: Citi upgrades Reliance Industries to Buy, TP Rs 1530; Bernstein on NTPC, MS on SBI Cards, Oberoi Realty, DLF, Auto Sector, PVC Pipes with TPs Rs 650, Rs 2060, Rs 910 and More 👇

Brokerage Reports: Citi upgrades Reliance Industries to Buy, TP Rs 1530; Bernstein on NTPC, MS on SBI Cards, Oberoi Realty, DLF, Auto Sector, PVC Pipes with TPs Rs 650, Rs 2060, Rs 910 and More 👇

Fitch Places Adani Energy Solutions and Adani Electricity Mumbai Default Ratings on Negative Watch Due to Bribery Charges

Fitch Places Adani Energy Solutions and Adani Electricity Mumbai Default Ratings on Negative Watch Due to Bribery Charges

Leave a Reply

Your email address will not be published. Required fields are marked *